Safety Warnings Added to Newer Diabetes Drugs (FREE)

By Kristin J. Kelley Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH The labels of sodium-glucose co-transporter 2 (SGLT2) inhibitors — drugs used to treat type 2 diabetes — will be updated to warn of the risks for ketoacidosis …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news